Autologous stem-cell transplantation in refractory autoimmune diseases after
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Autoimmune diseases that are resistant to conventional treatment cause severe morbidity and even mortality. In the present study we demonstrate that complete remissions can be achieved in refractory polychondritis and systemic lupus erythematosus (SLE), even at advanced stage, with the use of autologous stem-cell transplantation (SCT). Remissions persisted after reconstitution of the immune system. In the treatment of advanced systemic sclerosis (SSc), stable disease may be achieved with autologous SCT.
Data and resources (1)
- HTML
Official Government Data Source
Visit the original government dataset for complete information, documentation, and data access.
Modified Apr 29, 2026